GHISLAINE MAXWELL ACCT. For the Period 8/I/I I to 8/31/11 Account Summary Asset Allocation Beginning Ending Change Estimated Current Asset Allocation Market Value Market Value In Value Annual Income Allocation Equity Alternative Assets 323,294.00 59,860.00 318,597.00 (4,697.00) 15,632.50 11% 60,790.00 930.00 2% Cash 8 Fixed Income 2,236,346.58 2,611,943.13 375,596.55 78,448.27 87% Market Value Accruals 32,619,600.69 18,160 72 32,991,330.13 16,082.11 $371,829.66 (2,078.61) $94.080.77 100% Market Value with Accruals $2,637,661.30 $3,007,412.24 3369,760.94 Portfolio Activity Current Period Value Year-to-Date Value Beginning Market Value 2,619,600.68 1946,279.39 Contributions 545,420.04 805,513.35 1/1.4thdrawals 8 Fees (150,321.57) (152.299.92) Securities Transferred In 1,012,740.42 7,310,511.28 Securities Transferred Out (1,012,418.82) (7,562,372.85) Net Contributions/Withdrawals 0396,420.07 $401,361.86 Income 8 Distributions 7,148.45 56,338.93 Change In Investment Value (30,738.97) 587,359.95 Ending Market Value 32,991,330.13 32,991,330.13 Accruals 16,062.11 16,082.11 Market Value with Accruals $3,007,412.24 33,007,412.24 JP Morgan Alternative Assets Cases Fixed ASCOTS Page 2 of 24 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048093 SDNY_GM_00317291 EFTA01520757